New classes of alanine racemase inhibitors identified by high-throughput screening show antimicrobial activity against Mycobacterium tuberculosis.
(57/84)
(+info)
Alanine racemase mutants of Burkholderia pseudomallei and Burkholderia mallei and use of alanine racemase as a non-antibiotic-based selectable marker.
(58/84)
(+info)
Alanine racemase mutants of Mycobacterium tuberculosis require D-alanine for growth and are defective for survival in macrophages and mice.
(59/84)
(+info)
Thiadiazolidinones: a new class of alanine racemase inhibitors with antimicrobial activity against methicillin-resistant Staphylococcus aureus.
(60/84)
(+info)
Structural features and kinetic characterization of alanine racemase from Staphylococcus aureus (Mu50).
(61/84)
(+info)
Structure of alanine racemase from Oenococcus oeni with bound pyridoxal 5'-phosphate.
(62/84)
(+info)
Heavy-enzyme kinetic isotope effects on proton transfer in alanine racemase.
(63/84)
(+info)
Inhibition of mycobacterial alanine racemase activity and growth by thiadiazolidinones.
(64/84)
(+info)